U tijeku je upis prve generacije polaznika Sveučilišnog poslijediplomskog specijalističkog studija “Internistička onkologija” .
Stručni studij
HLZ- ESMO RSS
- Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC with HRAS Mutations 21. travnja 2021.
- FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma 20. travnja 2021.
- FDA Approves Nivolumab in Combination with Chemotherapy for Metastatic Gastric Cancer and Oesophageal Adenocarcinoma 19. travnja 2021.
- The IGCCCG Update Model Allows Improved and More Granular Individual Prognostic Assessment in Metastatic Non-Seminomatous Germ Cell Tumours 16. travnja 2021.
- Percentage of Cancer Patients Who Are Eligible for and Respond to Genome-Targeted Therapy Modestly Increased Over Time 15. travnja 2021.
